Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study

BACKGROUND: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Moerlie, Ashwin R., van Uden, Renate C., Mantel-Teeuwisse, Aukje K., Van Den Bemt, Patricia, Becker, Matthijs L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308913/
https://www.ncbi.nlm.nih.gov/pubmed/32587641
http://dx.doi.org/10.18549/PharmPract.2020.2.1803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308913/
https://www.ncbi.nlm.nih.gov/pubmed/32587641
http://dx.doi.org/10.18549/PharmPract.2020.2.1803

Ejemplares similares